L. Saragoni et al., Identification of occult micrometastases in patients with early gastric cancer using anti-cytokeratin monoclonal antibodies, ONCOL REP, 7(3), 2000, pp. 535-539
The presence of occult micrometastases was evaluated in 1488 lymph nodes re
moved from 139 patients with node-negative early gastric cancer (EGC). Addi
tional multiple levels of the lymph nodes were examined with haematoxylin-e
osin staining and keratin immunostaining. Occult nodal micrometastases were
detected in 24 patients (17%) in one or more lymph nodes dissected after a
gastrectomy. The cases investigated were a small group from a total of 412
EGC patients who underwent surgical treatment in our hospital between 1976
and 1997; the mean follow-up period was 9 years (range 1-22). We found no
significant differences between cytokeratin-negative and positive patients
regarding the following clinicopathological parameters: age, gender, tumour
size and site, macroscopic and microscopic type, depth of invasion and typ
e of infiltration, according to Kodama's classification. The survival rate
at 5 years was 88% and 87% for cytokeratin-negative and positive patients,
respectively (log-rank = 0.6; ns). Our data suggest that occult micrometast
ases do not add useful information and immunohistochemical studies to detec
t them are probably unnecessary.